S3 Group Selected as Design Partner on Europe's Largest Chronic Disease Management Program

S3 GroupS3 Group, a global enabler of scalable chronic disease management programs, announced that Telbios, technical and service provider of Buongiorno CReG, Europe's largest chronic disease service, has chosen them to provide design and consultancy services to enable the launch of the service in four health trust areas of Milano, Como, Bergamo and Milano-2. At a regional level almost 400 family physicians (MMGs) will provide care to approximately 40,000 chronic disease patients.

The Buongiorno CREG is the largest chronic disease management service in Europe and is being offered by a consortium of Telbios S.p.A and a collection of GPs (MMG) Co-Operatives. The purpose of the service is to manage patients with a primary diagnosis of Heart Failure, Diabetes Type I and Type II, Chronic Obstructive Pulmonary Disease (COPD), Hypertension and Ischemic Heart Disease in primary care settings or in their own homes.

The CReG Program will include a combination of services targeted at specific groups of chronically ill patients. The services will range from care co-ordination services and patient education to Tele-consultation and Telehealth. The roll-out of these services will be supported by a Telbios operated Service Center which will provide support for patients and for GP Co-Operatives who are delivering the service. The Service Center will also take responsibility for the monitoring of patients whose vital signs measurements have been captured remotely in patients' homes or GP offices and for provision of patient education and medication management services.

"We chose S3 Group as our service and solution design partner because of their deep domain expertise and specific experience in delivering a chronic disease management service. Our goal is to create specific care pathways for each chronic disease patient which can be tailored to their needs before being assigned and supervised. We are confident that S3 Group is the appropriate partner to help us achieve our goals and deliver a world-class offering that will bring huge savings and efficiencies to our health services in Italy." said Dr. Botti, CEO Telbios.

"The objective of the Buongiorno CReG Service is to create motivated and informed patients who can be treated in primary care settings or their own homes. Through our partnership with Telbios we are helping to design a service that ensures early intervention in the progression of a chronic disease and most importantly to enable the patients to take more control of their disease symptoms through education and vital sign readings. Through our work in the implementation of the Northern Ireland telemonitoring service we bring valuable experience to Telbios in the roll out of this large scale chronic disease management program in Italy and we are proud to have been chosen by them to be their partner." said Dr. Malachy Rice, Global Sales and Business Development Manager, S3 Group.

About S3 Group
S3 Group provides Telehealth consultancy services to healthcare providers, medical device vendors, primary care trusts, home healthcare agencies, accountable care organizations, and disease management companies. Our domain knowledge and experience, spanning the technological, clinical and business aspects of Telehealth, enables our clients to develop and implement robust, scalable, patient-centric holistic telehealth/telecare products and services that meet the needs of patients, their carers, clinical professionals and the wider healthcare system.

About Telbios
A pioneer in Telemedicine since 1996, Telbios has a unique case history with important public and private institutions and wide experience in the design and realization of programs and services to manage new pathways of care for the main chronic diseases and assistance of the patient at home. Telbios can count on a secure and reliable infrastructure for tele-monitoring (using terrestrial and mobile communications technologies) designed to support new ways to deliver healthcare and clinical research also through a Service Center open 24 hours a day for 365 days. Telbios has expertise in the use of medical information to create tailored, motivating directions for lifestyle improvement and health promotion. Member of Continua Health Alliance since 2007.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...